Skip to content

OCRA Board of Directors

Our Board

Distinguished leaders from fields including healthcare, law, entertainment, hospitality, and more make up our Board of Directors. While diverse in their areas of expertise, all of our members are united in their passion to advance ovarian and related gynecologic cancer research, help guide our path forward, and contribute toward our goal of finding a cure.

Related Topics

The Overview: November 2025

The Overview: November 2025

Friends, As we approach the end of the year, one thing stands out above all else: this is a moment of unprecedented opportunity to accelerate progress against ovarian and all gynecologic cancers. And thanks to you, OCRA is rising to meet that moment — driving innovation, expanding support, and providing the community that so many … Continued

Read more

OCRA Board Member Laura Shawver, PhD, Named to Fierce 50 of 2025

OCRA Board Member Laura Shawver, PhD, Named to Fierce 50 of 2025

Ovarian Cancer Research Alliance (OCRA) congratulates board member Laura Shawver, PhD, on her selection to the Fierce 50 of 2025, a leading industry award from Fierce Life Sciences recognizing individuals and organizations advancing what’s possible in health, science and patient care. Dr. Shawver was selected for her long-standing leadership in oncology research and drug development, … Continued

Read more

Make 2X the Difference with OCRA this Giving Season

Make 2X the Difference with OCRA this Giving Season

YOU Can Help Shape the Future of Ovarian and Gynecologic Cancer Care We need your help to reach our important $2 million year-end fundraising goal. Your donation will be matched up to $500,000 through 12/31, thanks to a generous OCRA board member. That means your $1 = $2 to improve care, foster hope, and bring … Continued

Read more

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.